Drasar E, Igbineweka N, Vasavda N, et al. Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years.
Br J Haematol. 2011 Mar;152(6):766-70. دُوِي:10.1111/j.1365-2141.2010.08451.x. Epub 2011 Jan 31. ببمد: 21275951
Davis BA، Allard S، Qureshi A، Porter JB، Pancham S، Win N، Cho G، Ryan K (يناير 2017). "Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects". British Journal of Haematology. ج. 176 ع. 2: 179–191. DOI:10.1111/bjh.14346. PMID:28092109. S2CID:3462324.
Drasar E, Igbineweka N, Vasavda N, et al. Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years.
Br J Haematol. 2011 Mar;152(6):766-70. دُوِي:10.1111/j.1365-2141.2010.08451.x. Epub 2011 Jan 31. ببمد: 21275951
Gyang E, Yeom K, Hoppe C, et al. Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease'Am J Hematol. 2011 Jan;86(1):104-6.
ببمد: 21117059
Mirre E, Brousse V, Berteloot L, et al. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease Eur J Haematol. 2010 Mar;84(3):259-65. Epub 2009 Nov 12.
ببمد: 19912310
Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000 Jul 1;96(1):76-9. ببمد: 10891433
pubmed.ncbi.nlm.nih.gov
Davis BA، Allard S، Qureshi A، Porter JB، Pancham S، Win N، Cho G، Ryan K (يناير 2017). "Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects". British Journal of Haematology. ج. 176 ع. 2: 179–191. DOI:10.1111/bjh.14346. PMID:28092109. S2CID:3462324.
Davis BA، Allard S، Qureshi A، Porter JB، Pancham S، Win N، Cho G، Ryan K (يناير 2017). "Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects". British Journal of Haematology. ج. 176 ع. 2: 179–191. DOI:10.1111/bjh.14346. PMID:28092109. S2CID:3462324.